Sh-Polypeptide-86 for Hair Regrowth - Quick Reference Sheet

Sh-Polypeptide-86 for Hair Regrowth

Created on 08/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A lab-made copy of the protein follistatin, added to scalp serums to block signals that keep hair follicles resting. The underlying biology is well supported in animal studies, but the only human evidence used an injected mixture, not a topical serum. Whether the large protein even reaches follicles from a serum is unresolved. (Full Review)

Protocol

Frequency
Once daily
1 to a few dropper-fulls to a clean, dry scalp
Application
Topical to scalp
Massaged into the thinning area and left on
Consistency
≥4 months
Emphasized as more important than dose
Time to effect
First visible change
3–4 months
Minimum with consistent daily use
Realistic assessment
6 months
More realistic point to judge effect

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • History of scalp/skin cancer or undiagnosed suspicious scalp lesion
  • Active scalp infection, open wounds, or scarring alopecia
Key Interactions
  • Topical hair-loss drugs (minoxidil, finasteride)
  • Topical retinoids and exfoliating acids (tretinoin, adapalene, glycolic/salicylic acid)
  • OTC scalp products (medicated shampoos, benzoyl peroxide, alcohol-based tonics)
  • Microneedling and injectable mesotherapy

Risk & Side Effects

  • High:
  • Medium:
  • Low: Application-site irritation and contact dermatitis; scalp folliculitis and pruritus
  • Speculative: Theoretical tumor-promoting potential; systemic myostatin and activin effects with absorption; immunogenicity and unknown long-term safety

Monitoring

Marker Target Why
Ferritin (iron stores) 40–70 ng/mL Low iron stores are a common, correctable cause of shedding that can mask any benefit
Vitamin D, 25-hydroxy (25-OH-D) 40–60 ng/mL Low vitamin D is associated with hair shedding and follicle cycling problems
Thyroid-stimulating hormone (TSH) 0.5–2.5 mIU/L Both under- and over-active thyroid cause diffuse hair loss that mimics or masks pattern loss
Total and free testosterone Mid-normal for age and sex Helps contextualize androgen-driven loss, which a follistatin serum does not address
Dihydrotestosterone (DHT) Sex-appropriate reference The main androgen driving follicle miniaturization; frames whether a DHT-directed therapy is also needed

Cadence: Photos at 3 and 6 months, then every 6 months; repeat blood markers only if baseline values were abnormal or symptoms change

Qualitative Assessment

  • Daily hair shedding trending down or stabilizing
  • Subjective scalp coverage and "fullness," especially at the hairline and crown
  • Hair caliber — whether regrowth comes in thin and wispy or thicker and pigmented
  • Scalp comfort — absence of persistent redness, itching, or bumps